MIDLAND, MI – The Dow Oxygenated Solvents business announced an expansion plan to increase capacity of butyl glycol ethers at its Seadrift, TX, facility. The plan is part of a two-phase debottleneck project that will increase capacity of Butyl CELLOSOLVE™ Solvent and Butyl CARBITOL™ Solvent by 15 percent. Phase One will be completed later this month, followed by Phase Two, which will be finished during a planned turnaround this fall. 

Mark Bassett, Global Business Director for Oxygenated Solvents, said, “This expansion, in addition to Dow’s investment in Sadara, demonstrates Oxygenated Solvents' commitment to our customers’ growth needs. The Seadrift debottleneck is the first of a series of announcements that will highlight major projects that are currently underway within the business. These investments reinforce our commitment to the market and being the world’s premier supplier of oxygenated solvents.”